Skip to main navigation Skip to search Skip to main content

High-dose ascorbic acid in metastatic castration-resistant prostate cancer: evalution of efficacy and safety in a phase II trial.

Torben Kjær Nielsen , Martin Højgaard, Henrik Enghusen Poulsen, Jens Lykkesfeldt, Niklas Rye Jørgensen, Kari Joensen Mikines

Original languageEnglish
Publication date2015
Publication statusPublished - 2015
EventNordisk Urologisk Forening - Malmø, Sweden
Duration: 3 Jun 20155 Jun 2015

Conference

ConferenceNordisk Urologisk Forening
Country/TerritorySweden
CityMalmø
Period03/06/201505/06/2015

Cite this